News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
246 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (271)
2 (281)
3 (275)
4 (131)
5 (1)
6 (2)
7 (16)
8 (364)
9 (350)
10 (293)
11 (152)
12 (2)
13 (18)
14 (265)
15 (311)
16 (221)
17 (246)
18 (119)
19 (10)
20 (22)
21 (217)
22 (249)
23 (226)
24 (235)
25 (118)
26 (2)
27 (5)
28 (204)
29 (282)
30 (224)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Deals
LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs
Funding to support advancement of powerful bispecific gamma-delta T cell engager programs for the treatment of a broad range of cancers
September 17, 2020
·
3 min read
Cannabinoid Therapy Market: Growing Cancer cases across the world is a significant contributor of market growth
Cannabinoids are chemicals found both in plants and in pain relieving pathways in human neural networks.
September 17, 2020
·
4 min read
Drug Eluting Beads Market: Rise in number of liver diseases around the world is expected to drive market growth
Expansive growth opportunities are forecasted for the drug eluting beads market across the forecast period of 2020-2030.
September 17, 2020
·
5 min read
Hormone Refractory Prostate Cancer Market - Systematic Reimbursement Policies and Quick FDA Approvals Serve as Robust Pillars of Growth
The hormone refractory prostate cancer market may gain good growth during the forecast period of 2019-2029 on the back of the rising prevalence of this type of prostate cancer across the globe.
September 17, 2020
·
3 min read
Peptide Array Services Market: Increased Demand from laboratories for Clinical Tests to Fuel Market Growth
Peptide arrays are formed when a large number of peptides are arranged spatially in an addressable format and with the help of a solid support.
September 17, 2020
·
5 min read
Animal Genetics Market: Live animals segment to account for major share
Expansion of the economies of emerging markets, such as Asia Pacific and Latin America, is projected to offer considerable opportunity to the animal genetics market.
September 17, 2020
·
5 min read
Dermal Fillers Market: Biodegradables is anticipated to be a lucrative segment
Dermal fillers can be defined as soft tissue fillers injected into the skin for the restoration of smoother appearance and reduction of wrinkles and signs of aging.
September 17, 2020
·
5 min read
Shoulder Replacement Market: Players Need to Tread Cautiously in Cost-Sensitive Markets
The authors of the report maintain a bullish stance on the future of the shoulder replacement market, with a cohort of drivers dictating its growth.
September 17, 2020
·
6 min read
Genetown
Genocea Presents Follow-up Data from GEN-009 Neoantigen Vaccine Phase 1/2a Trial at ESMO Virtual Congress 2020
Step-down responses to GEN-009, with 3 objective responses (2 PR, 1 CR) in the first 5 patients, suggests added benefit to PD-1 inhibitor therapy
September 17, 2020
·
4 min read
Drug Development
New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at ESMO Virtual Congress 2020
Data is part of Genentech’s MORPHEUS umbrella program and covers patients with resistant/refractory NSCLC treated with ciforadenant in combination with atezolizumab
September 17, 2020
·
8 min read
Previous
11 of 25
Next